or Try an Advanced Search...

    Technical Analysis for ALLO - Allogene Therapeutics, Inc.

    Grade Last Price % Change Price Change
    F 2.33 0.00% 0.00
    ALLO closed unchanged on Monday, July 1, 2024, on 77 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical ALLO trend table...
    Date Alert Name Type % Chg
    Bollinger Band Squeeze Range Contraction 0.00%
    NR7 Range Contraction 0.00%
    Inside Day Range Contraction 0.00%
    Fell Below 20 DMA Bearish 0.00%
    Bollinger Band Squeeze Range Contraction 0.00%
    Crossed Above 20 DMA Bullish -4.51%
    Bollinger Band Squeeze Range Contraction -4.51%
    20 DMA Resistance Bearish -0.43%
    Bollinger Band Squeeze Range Contraction -0.43%
    Fell Below 20 DMA Bearish -2.92%
    Older End-of-Day Signals for ALLO ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 about 6 hours ago
    Possible Inside Day about 6 hours ago
    10 DMA Resistance about 10 hours ago
    Up 3% about 10 hours ago
    Up 2% about 10 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    ALLO Chart by TradingView
    Basic chart:

    Profile

    Allogene Therapeutics is a clinical stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) therapies for cancer. Led by a world-class management team with significant experience in cell therapy, we are developing a pipeline of “off-the-shelf” CAR T cell therapy candidates with the goal of delivering readily available cell therapy faster, more reliably and at greater scale to more patients.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Cancer Life Sciences Stem Cell Cell Therapy Cell Biology Therapies For Cancer Adoptive Cell Transfer

    Is ALLO a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jul 1 Allogene Therapeutics Activates Three Community Cancer Centers as First Sites for the Pivotal Phase 2 ALPHA3 Trial Evaluating Cemacabtagene Ansegedleucel (cema-cel) as First Line (1L) Consolidation Treatment for Patients with Large B-Cell Lymphoma (LBCL)
    Jun 27 With 56% institutional ownership, Allogene Therapeutics, Inc. (NASDAQ:ALLO) is a favorite amongst the big guns
    Jun 27 Allogene Therapeutics, Inc. (ALLO): Are Analysts Bullish About the Potential of This Small-Cap Stock?
    Jun 20 Allogene Therapeutics Initiates Pivotal Phase 2 Trial Investigating Cemacabtagene Ansegedleucel (cema-cel), an Allogeneic CAR T Product, as Part of First Line Treatment for Patients with Large B-Cell Lymphoma (LBCL) Likely to Relapse
    Jun 12 Allogene: Two End Of 2024 Data Readouts With Improved Allogeneic CAR-T Products
    Jun 12 Allogene Therapeutics (ALLO) Down 13.9% Since Last Earnings Report: Can It Rebound?
    May 29 Insiders Pour Millions Into These 2 ‘Strong Buy’ Stocks
    May 28 If You Can Only Buy One Penny Stock in May, It Better Be One of These 3 Names
    May 23 Allogene Therapeutics Announces Participation in the TD Cowen 5th Annual Oncology Innovation Summit
    May 15 Why Arcutis Biotherapeutics Shares Are Trading Higher By 29%; Here Are 20 Stocks Moving Premarket
    See more ALLO news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 5.995
    52 Week Low 2.18
    Average Volume 2,904,007
    200-Day Moving Average 3.32
    50-Day Moving Average 2.67
    20-Day Moving Average 2.42
    10-Day Moving Average 2.40
    Average True Range 0.19
    RSI (14) 42.53
    ADX 14.17
    +DI 20.17
    -DI 27.13
    Chandelier Exit (Long, 3 ATRs) 2.11
    Chandelier Exit (Short, 3 ATRs) 2.75
    Upper Bollinger Bands 2.63
    Lower Bollinger Band 2.22
    Percent B (%b) 0.28
    BandWidth 17.05
    MACD Line -0.10
    MACD Signal Line -0.11
    MACD Histogram 0.0175
    Fundamentals Value
    Market Cap 392.09 Million
    Num Shares 168 Million
    EPS -2.20
    Price-to-Earnings (P/E) Ratio -1.06
    Price-to-Sales 3962.65
    Price-to-Book 1.26
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.50
    Resistance 3 (R3) 2.50 2.46 2.47
    Resistance 2 (R2) 2.46 2.41 2.45 2.46
    Resistance 1 (R1) 2.39 2.39 2.39 2.39 2.45
    Pivot Point 2.35 2.35 2.34 2.34 2.35
    Support 1 (S1) 2.28 2.30 2.28 2.28 2.21
    Support 2 (S2) 2.24 2.28 2.23 2.20
    Support 3 (S3) 2.17 2.24 2.19
    Support 4 (S4) 2.17